Author

Anne Chotteau‐Lelièvre

Centre de Recherches en Cancérologie de LilleORCID 0000-0002-7051-1792Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Agathe LaratteiD· 1 shared Alexis Benjamin CortotiD· 1 shared Andréa ParadisiiD· 1 shared Audrey VinchentiD· 1 shared Céline VillenetiD· 1 shared Céline VuillieriD· 1 shared Clotilde DescarpentriesiD· 1 shared David TulasneiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Agathe LaratteORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 10, 2025

Oncogenic mutations convert MET from a pro-apoptotic tumor suppressor to an oncogenic driver

Rémi Tellier, Marie Fernandes, Audrey Vinchent…·David Tulasne

The paper shows that MET exon 14 skipping mutations eliminate the pro-apoptotic function of MET, converting it from a tumor suppressor to an oncogenic driver in lung adenocarcinomas.

DOI 10.1101/2025.11.10.687614

mouseexperimental assay

𝕏 PostBluesky